デフォルト表紙
市場調査レポート
商品コード
1058837

バイオチップの世界市場(2021年~2028年)

Global Biochips Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 190 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
バイオチップの世界市場(2021年~2028年)
出版日: 2022年02月16日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 約2営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のバイオチップ市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界のバイオチップ市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界のバイオチップ市場-市場の定義と概要

第3章 世界のバイオチップ市場-エグゼクティブサマリー

  • 市場の内訳:製品タイプ別
  • 市場の内訳:アプリケーション別
  • 市場の内訳:技術別
  • 市場の内訳:エンドユーザー別
  • 市場の内訳:地域別

第4章 世界のバイオチップ市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界のバイオチップ市場-業界分析

  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ

第6章 世界のバイオチップ市場-COVID-19分析

  • 市場でのCOVID-19の分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界のバイオチップ市場:製品タイプ別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):製品タイプ別
    • 市場魅力指数:製品タイプ別
  • DNAチップ*
    • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • プロテインチップ
  • ラボオンチップ
  • その他

第8章 世界のバイオチップ市場:アプリケーション別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):アプリケーション別
    • 市場魅力指数:アプリケーション別
  • 創薬*
    • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • ゲノミクス
  • プロテオミクス
  • 病気の診断
  • その他

第9章 世界のバイオチップ市場:技術別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):技術別
    • 市場魅力指数:技術別
  • マイクロアレイ*
    • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • マイクロフルイディクス
  • その他

第10章 世界のバイオチップ市場:エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 病院および診断センター*
    • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • 学術・研究施設
  • バイオテクノロジーおよび製薬企業
  • その他

第11章 世界のバイオチップ市場:地域別

  • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年):地域別
    • 市場魅力指数:地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第12章 世界のバイオチップ市場-競合情勢

  • 主な発展と戦略
  • 企業シェア分析
  • 製品のベンチマーク
  • 注目すべき主要企業のリスト

第13章 世界のバイオチップ市場-企業プロファイル概要

  • Bio-Rad Laboratories Inc.*
    • 企業概要
    • 製品ポートフォリオおよび説明
    • 主要ハイライト
    • 財務概要
  • Agilent Technologies Inc.
  • Fluidigm Corporation
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • PerkinElmer Inc.
  • Illumina, Inc.
  • Cepheid Inc.
  • Sigma Aldrich
  • Sofchip

第14章 世界のバイオチップ市場-DataM

  • 付録
  • 当社とアプリケーションについて
  • お問い合わせ
目次
Product Code: DMHCIT4653

Market Overview

The Global "Biochips Market" is Expected to reach at a CAGR of 11 % during the forecast period (2021-2028).

Biochips refer to a miniaturized device capable of performing thousands of biochemical reactions and are used in molecular biology. Their unique features include thousands of biochemical reactions used in molecular biology. These are utilized in various applications such as research applications in biotechnology such as genomics and proteomics, molecular diagnostics and drug screening and development.

Market Dynamics

The technological advancement of biochips is expected to drive market growth.

The emergence of next-generation sequencing technology, which has a short read length, high measurement throughput, and low cost, has changed life science, medicine, and even computer science. The development of third-generation sequencing technologies, such as nanopore and zero-mode waveguide techniques, has resulted in even faster and longer read lengths, with promising applications in portable and rapid genomic studies in the field. Issues such as public health emergencies and global pandemics, especially in the current climate, demand rapid identification of analyte origins and species via DNA sequences. In addition, future development of disease diagnosis, treatment, and tracking techniques may also require frequent DNA testing. As a result, DNA sequencers with miniaturized size and highly integrated components for personal and portable use to tackle increasing needs for disease prevention, personal medicine, and biohazard protection may become future trends. Like many other biological and medical analytical systems that were originally bulky in sizes, collaborative work from various subjects in engineering and science eventually led to the miniaturization of these systems. DNA sequencers that involve nanoprobes, detectors, microfluidics, microelectronics, circuits, and complex functional materials and structures are extremely complicated but maybe miniaturized with technical advancement. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

The high cost of biochips, lack of awareness regarding biochip technologies, and stringent regulatory guidelines are a few factors the market is expected to hamper in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic had a positive impact on the market. Sensitive detection of SARS-CoV-2 is of great importance for inhibiting the current pandemic of COVID-19. A simple yet efficient platform integrates a portable and low-cost custom-made detector and a novel microwell array biochip for rapid and accurate detection of SARS-CoV-2. The instrument exhibits expedited amplification speed that enables colorimetric read-out within 25 minutes. Moreover, Based on reverse transcriptase loop-mediated isothermal amplification, a polymeric chip with a laser-engraved microwell array was designed to process the reaction between the primers and the respiratory swab RNA extracts (RT-LAMP). To acquire clinically acceptable results, created a set of six primers to identify the conserved sections of the SARS-CoV-2 ORF1ab gene. Thus, this is owing to boost the biochips market in the forecast period.

Segment Analysis

Lab-on-a-chip segment is expected to hold the largest market share in biochips market

The Lab-on-a-chip segment is expected to dominate in 2020. The segment benefits because it includes dramatically reduced sample size, much shorter reaction and analysis time, high throughput, automation, and portability. The key microfluidic functions required in various lab-on-a-chip devices include pumping, mixing, thermal cycling, dispensing, and separating. Moreover, increasing research on LOC is expected to boost the market in the forecast period. For instance, The University of Alberta's top researchers has worked together to create a portable LOC device for detecting COVID-19 antibodies quickly. A low-cost imaging platform based on the lab-on-a-chip technology developed by University of California Irvine scientists could also be available for quick coronavirus diagnosis and antibody testing. Therefore, it has increased the demand for Lab-on-a-chip technology, due to which the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global biochips market

In 2020, North America accounted for the highest revenue share. The growing geriatric population, increasing prevalence of cardiovascular diseases and cancer, product launches and approvals by the market players, and technological advancements in biochip technologies are factors that the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, Coronary heart disease is the most common type of heart disease, killing 360,900 people in 2019. About 18.2 million adults age 20 and older have CAD (about 6.7%). About 2 in 10 deaths from CAD happen in adults less than 65 years old.

Moreover, In the United States, interest in high throughput screening (HTS) technology in academic research has increased. The Society for Biomolecular Sciences maintains a comprehensive database of academic screening centers. It provides academics with HTS resources, but it also assists in identifying probes and leads for drug discovery. Additionally, The US Food and Drug Administration (FDA) granted PathogenDx, Inc. an Emergency Use Authorization (EUA) for their patented COVID-19 multiplexed viral diagnostic test, DetectX-Rv, in April 2021. DetectX-Rv is a qualitative nucleic acid detection assay based on RT-PCR and DNA microarray hybridization from SARS-CoV-2 swabs. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the biochips market are Bio-Rad Laboratories Inc., Agilent Technologies Inc., Fluidigm Corporation, Thermo Fisher Scientific, Abbott Laboratories , PerkinElmer Inc., Illumina, Inc., Cepheid Inc., Sigma Aldrich and Sofchip.

Thermo Fisher Scientific:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and is based in Waltham, Massachusetts. The company offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services worldwide. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Product Portfolio:

GeneChip Hybridization Oven: The GeneChip Hybridization Oven 645 provides precise temperature and rotation control to help ensure the successful hybridization of as many as 64 GeneChip-brand cartridges at one time.

Why Purchase the Report?

Visualize the composition of the biochips market segmentation by product type, application, technology, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in biochips market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of biochips market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global biochips market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Biochips Market - By Product Type

DNA Chip

Protein Chip

Lab-on-a-chip

Others

Global Biochips Market - By Application

Drug Discovery

Genomics

Proteomics

Disease Diagnostics

Others

Global Biochips Market - By Technology

Microarrays

Microfluidics

Others

Global Biochips Market - By End user

Hospitals & Diagnostics Centers

Academic & Research Institutes

Biotechnology & Pharmaceutical Companies

Others

Global Biochips Market - By Region

North America

South America

Europe

Asia

Middle East & Africa

Table of Contents

1. Global Biochips Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Biochips Market - Market Definition and Overview

3. Global Biochips Market - Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Technology
  • 3.4. Market Snippet by End user
  • 3.5. Market Snippet by Region

4. Global Biochips Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The technological advancement of biochips is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of biochips is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Biochips Market - Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs

6. Global Biochips Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Biochips Market - By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. DNA Chip*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Protein Chip
  • 7.4. Lab-on-a-chip
  • 7.5. Others

8. Global Biochips Market - B Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Drug Discovery*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Genomics
  • 8.4. Proteomics
  • 8.5. Disease Diagnostics
  • 8.6. Others

9. Global Biochips Market - By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology Segment
  • 9.2. Microarrays*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Microfluidics
  • 9.4. Others

10. Global Biochips Market - By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Hospitals & Diagnostics Centers*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Academic & Research Institutes
  • 10.4. Biotechnology & Pharmaceutical Companies
  • 10.5. Others

11. Global Biochips Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Global Biochips Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Global Biochips Market- Company Profiles

  • 13.1. Bio-Rad Laboratories Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Agilent Technologies Inc.
  • 13.3. Fluidigm Corporation
  • 13.4. Thermo Fisher Scientific
  • 13.5. Abbott Laboratories
  • 13.6. PerkinElmer Inc.
  • 13.7. Illumina, Inc.
  • 13.8. Cepheid Inc.
  • 13.9. Sigma Aldrich
  • 13.10. Sofchip

LIST NOT EXHAUSTIVE

14. Global Biochips Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us